HCPCS Level IIdrugActive
J9341
Inj thiotepa (tepylute) 1 mg
BETOS: O1D
Effective: 2025-07-01
Description
Injection, thiotepa (tepylute), 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Tepylute
Manufacturer
Shorla Oncology Inc.
HCPCS Dosage
1 MG
Billing Units
15.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.